- Report
- September 2022
- 173 Pages
North America
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- July 2022
- 241 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- April 2023
- 112 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- February 2024
- 75 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- June 2023
- 135 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- January 2021
- 149 Pages
China, Global
From €3000EUR$3,303USD£2,660GBP
- Report
- January 2021
- 149 Pages
China, Global
From €3000EUR$3,303USD£2,660GBP
- Report
- April 2024
United Kingdom
From €2038EUR$2,095USD£1,746GBP
€3882EUR$3,990USD£3,326GBP
- Report
- March 2023
- 132 Pages
Global
From €924EUR$950USD£792GBP
- Report
- October 2023
- 306 Pages
Global
From €5575EUR$5,730USD£4,776GBP
- Report
- April 2023
- 147 Pages
Global
From €5837EUR$5,999USD£5,000GBP
- Book
- October 2019
- 720 Pages
Erythromycin is an antibiotic used to treat a variety of bacterial infections, including those caused by certain strains of streptococcus, staphylococcus, and mycoplasma. It is commonly used to treat infections of the respiratory tract, skin, and soft tissue, as well as certain sexually transmitted diseases. In the context of infectious diseases drugs, erythromycin is a widely used antibiotic, with a long history of safe and effective use. It is generally well tolerated, with few side effects, and is available in both oral and intravenous formulations.
Erythromycin is available in generic form, as well as under several brand names. Some of the companies that produce erythromycin include Pfizer, Merck, and GlaxoSmithKline. Show Less Read more
